ArticlePloS one2026
Network pharmacological insight into traditional bone healing practices of Sikkim, India.
Article in PloS one, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
31 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
ethnopharmacological relevanceSikkim is a mountainous state situated in the Eastern Himalaya region of India, which constitutes an area with rich cultural diversity, having different traditional healthcare practices and rituals. Traditional formulations for treating bone fractures are prevalent in rural areas of Sikkim.
aimThe present study was designed to document and analyse the traditional knowledge, practices, and medicinal plants used by traditional healers of Sikkim for the treatment of Bone fractures. And network pharmacological perspectives on the bone-mending properties of the medicinal plants used by the traditional healers of Sikkim.
methodSemi-structured questionnaires, semi-structured interviews, and guided field walks were used in this explorative study for four years in all six districts of Sikkim, India. The quantity indices frequency of citation (FoC) and Relative Frequency of Citation (RFC) are used to authenticate the most important medicinal plant species. Further, to examine the intricate relationships among drugs, targets, and diseases, we conducted network pharmacological annotations using several advanced tools, including Swiss Target Prediction, STRING, STITCH, DAVID, GeneCodis, and SwissADME.
resultsThe study documented 18 distinct traditional polyherbal formulations that incorporate 32 medicinal plant species native to Sikkim and are utilised for the therapeutic management of bone fractures. Notably, several plant species identified in this investigation, particularly those exhibiting high Frequency of Citation (FoC) values, represent promising candidates for further pharmacological evaluation targeting osteoregenerative properties. Additionally, four plant species, Urtica parviflora Roxb., Saurauia napaulensis DC., Rubus calycinus Wall. ex D.Don, and Schima wallichii (DC.) Korth., employed by traditional healers in this study, warrant prioritised phytochemical investigation due to their limited scientific exploration in existing literature. The network pharmacological annotations revealed several pathways that are directly or indirectly affecting bone development, biomineralisation, calcium signalling, endochondral ossification with skeletal dysplasia, RANK signalling, RUNX2 regulation, and Vitamin D-sensitive Ca signalling.
conclusionThis study systematically documents traditional treatments for bone fractures in Sikkim, highlighting 32 medicinal plants with therapeutic potential. The findings of this study will provide baseline data to address an immediate need to preserve and scientifically validate (in vivo and in vitro) indigenous ethnomedicinal knowledge. Furthermore, provide valuable insights into the development of safe and effective lead compounds by considering the biological processes, molecular functions, and cellular components involved in bone mending from natural formulations.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.